GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Pre-Tax Income

argenx SE (argenx SE) Pre-Tax Income : $-304 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. argenx SE's pretax income for the three months ended in Dec. 2023 was $-61 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-304 Mil. argenx SE's pretax margin was -15.04%.

During the past 13 years, argenx SE's highest Pretax Margin was -24.83%. The lowest was -1467.76%. And the median was -200.48%.


argenx SE Pre-Tax Income Historical Data

The historical data trend for argenx SE's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Pre-Tax Income Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.92 -605.35 -399.74 -729.31 -304.50

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.24 -76.18 -83.86 -83.28 -61.18

Competitive Comparison of argenx SE's Pre-Tax Income

For the Biotechnology subindustry, argenx SE's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where argenx SE's Pre-Tax Income falls into.



argenx SE Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

argenx SE's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-420.638+24.084+-0.904+92.962+0
=-304

argenx SE's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-136.836+50.052+-0.278+25.884+1.4210854715202E-14
=-61

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-304 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE  (NAS:ARGX) Pre-Tax Income Explanation

argenx SE's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-61.178/406.837
=-15.04%

During the past 13 years, argenx SE's highest Pretax Margin was -24.83%. The lowest was -1467.76%. And the median was -200.48%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of argenx SE's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (argenx SE) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.